NCT07518056 Relationships Between Nomophobia Levels and Perceived Stress, Body Image and Food Addiction Among University Students
| NCT ID | NCT07518056 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bahçeşehir University |
| Condition | Nomofobia |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2026-02-10 |
| Primary Completion | 2026-04-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The purpose of this study is to examine the effects of nomophobia levels on stress, food addiction, and body image among undergraduate students aged 18-30 at Bahçeşehir University, Faculty of Health Sciences. The primary questions it aims to answer are: * Is there a statistically significant relationship between nomophobia levels and perceived stress, food addiction, and body image among university students? * Is there a correlation between objective anthropometric data (body fat percentage, skeletal muscle mass) measured via Bioelectrical Impedance Analysis (BIA), waist/hip circumference measurements, and the individual's perceived body image?
Eligibility Criteria
Inclusion Criteria: * Being an active smartphone user * Reading and providing consent via the Informed Consent Form * Absence of conditions such as pacemaker implantation, metallic prostheses in the body, or pregnancy * Not having a diagnosed metabolic disorder (e.g., Cushing's syndrome, diabetes, thyroid disorders) or any acute/chronic psychiatric condition that may affect eating behavior Exclusion Criteria: * Individuals with a current diagnosis of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder, etc.) * Individuals with a psychiatric diagnosis of severe depression, bipolar disorder, psychotic disorder, or an anxiety disorder requiring treatment * Individuals who regularly use psychiatric medications (e.g., SSRIs, SNRIs, antipsychotics, mood stabilizers, etc.) * Individuals who have used corticosteroids or similar hormone-regulating medications in the past 3 months * Pregnant or breastfeeding individuals * Participants who did not complete the quest